CTIP2 is a negative regulator of P-TEFb

Area of Science:

• Molecular Biology
• Gene Regulation
• Cellular Signaling

Background:

• Positive transcription elongation factor b (P-TEFb) is crucial for cellular processes and disease.
• Maintaining the balance of active and inactive P-TEFb is vital for cell integrity.
• Dysregulation of P-TEFb is implicated in inflammation, cancer, AIDS, and cardiac hypertrophy.

Purpose of the Study:

• To investigate the role of the transcriptional repressor CTIP2 in modulating P-TEFb activity.
• To elucidate the mechanism by which CTIP2 interacts with and regulates P-TEFb.
• To determine the physiological and pathological relevance of CTIP2-mediated P-TEFb control.

Main Methods:

• Co-purification and interaction studies to identify CTIP2-P-TEFb complex components.
• In vitro kinase assays to measure P-TEFb Cdk9 activity.
• Analysis of gene expression profiles sensitive to P-TEFb and 7SK snRNA.
• Investigation of CTIP2 and P-TEFb localization at the MYH7 gene promoter in a mouse model of cardiac hypertrophy.

Main Results:

• CTIP2 was identified as a major modulator of P-TEFb activity, interacting with the inactive P-TEFb complex (containing 7SK snRNA and HEXIM1).
• CTIP2 directly binds HEXIM1 and P-TEFb via 7SK snRNA, significantly repressing P-TEFb's Cdk9 kinase activity.
• CTIP2 inhibits the expression of numerous P-TEFb- and 7SK snRNA-sensitive genes.
• In hypertrophic hearts, CTIP2 controls P-TEFb-sensitive pathways, including repressing the MYH7 gene promoter, contributing to cardiac pathology.

Conclusions:

• CTIP2 acts as a key regulator of P-TEFb function by forming a repressive complex.
• CTIP2's regulation of P-TEFb is critical in both normal physiological conditions and pathological states like cardiac hypertrophy.
• Targeting the CTIP2-P-TEFb interaction may offer therapeutic strategies for diseases involving P-TEFb dysregulation.